An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
This study is for people with a severe inherited bleeding condition called Type 3 Von Willebrand Disease. If you're already receiving regular treatment (called 'prophylaxis') for this condition, this study might be for you. Researchers want to learn more about how well these treatments work in real life and how they affect your health and quality of life. They will simply observe your usual care for at least 24 weeks, without changing your treatment. This helps us understand what works best and how to improve care for others with Type 3 Von Willebrand Disease.
A colpo d'occhio
Di cosa tratta questo studio?
This study is for individuals already diagnosed with a serious inherited bleeding disorder called Type 3 Von Willebrand Disease (VWD). This condition means your blood doesn't clot properly, leading to bleeding problems.
The main goal of this study is to gather information on how effective and safe the treatments you currently receive are. You won't be given any new medicines or asked to change your current treatment. Instead, the study will simply observe what you're already doing with your doctor and how your condition affects your daily life over about six months. This approach helps researchers understand the 'real world' impact of current treatments.
By collecting details about your health and how you feel, the study aims to improve our understanding of Type 3 VWD and how best to manage it. This information can help doctors and researchers find better ways to care for people with this condition in the future. It's a way to learn from those who live with VWD every day.
Punti chiave
- Study for people with Type 3 Von Willebrand Disease already on standard treatment.
- Observes your current care; no new drugs are given.
- Aims to understand treatment effectiveness and quality of life.
- Participating will last at least 24 weeks (6 months).
- Helps improve future care for others with VWD.
- Your medical care will not be affected if you choose not to participate or withdraw.
Chi può essere idoneo?
To join this study, you must have a confirmed diagnosis of severe Type 3 Von Willebrand Disease. You also need to be receiving your usual, regular treatment (called 'prophylactic therapy') for your condition, typically taking it 1 to 3 times a week, and expect to continue this treatment during the study period. Your blood, liver, and kidney functions should be generally healthy.
There are also some important reasons why you might not be able to join. For example, if you have another bleeding disorder, a recent history of stomach or bowel bleeding, or a history of bleeding in the brain, you wouldn't be suitable. People who have had blood clots or are being treated for them, or those with certain other medical conditions affecting bleeding or clotting, would also not be able to participate.
Additionally, if you are pregnant, planning to become pregnant, or are of childbearing age, you would need to agree to use effective contraception throughout the study. If you're taking certain strong immune-system affecting medications (like systemic immunomodulators), you also wouldn't be able to join, though some specific medications like HIV treatments are exceptions.
Questo studio potrebbe fare al caso tuo?
Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.
- Do I have a confirmed diagnosis of Type 3 Von Willebrand Disease?
- Am I currently receiving regular (prophylactic) treatment for my VWD?
- Am I generally healthy aside from my VWD, with good liver/kidney function?
- Have I had any recent stomach/bowel bleeds or bleeds in the brain?
- Am I pregnant or planning to become so soon?
- Am I generally able to attend appointments without major issues?
Cosa comporta la partecipazione?
If you decide to take part, you will continue with your regular medical appointments and treatments as prescribed by your doctor. The study will mainly involve collecting information from your medical records and asking you about your health and quality of life through questionnaires. This will happen over at least 24 weeks (about 6 months).
You won't receive any new medications or treatments specially for the study. Instead, the researchers will observe your usual care. You'll likely have regular check-ups with the study team to record information, but these are typically planned around your existing appointments. There's no strict number of visits mentioned, as it follows your standard care.
Rischi e benefici potenziali
Località (25)
- UC DavisCodice postale verificatoSacramento, Stati Uniti
- University of Minnesota Medical CenterCodice postale verificatoMinneapolis, Stati Uniti
- Washington University School of MedicineCodice postale verificatoSt Louis, Stati Uniti
- UZ Leuven GasthuisbergCodice postale verificatoLovanio, Belgio
- L'Ospedale per Bambini MalatiCodice postale verificatoToronto, Canada
- McGill University Health CenterCodice postale verificatoMontreal, Canada
- IPS SURA Industriales MedellínCodice postale verificatoMedellín, Colombia
- Hopital Claude Huriez - CHU LilleCodice postale verificatoLille, Francia
- Groupe Hospitalier Necker Enfants MaladesCodice postale verificatoParigi, Francia
- Universitätsklinikum BonnCodice postale verificatoBonn, Germania
- Gerinnungszentrum Rhein-Ruhr;GerinnungsambulanzCodice postale verificatoDuisburg, Germany
- Hämophiliezentrum Med. Klinik III/Institut für TransfusionsmedizinNon verificatoFrankfurt/M., Germany
Domande comuni
What is Type 3 Von Willebrand Disease?
It's a serious inherited bleeding disorder where your blood doesn't clot properly, leading to increased bleeding.
Will my treatment change if I join this study?
No, you will continue with your current, regular treatment as usual. The study just observes it.
Per quanto tempo sarò nello studio?
You will be observed for at least 24 weeks, which is about 6 months.
Do I need to visit the hospital more often for this study?
The study aims to fit around your existing appointments, so you shouldn't have many extra visits.
What kind of information will they collect?
They will collect details from your medical records and ask you questions about your health and how you feel.
Come saperne di più
Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.
Discussione
Discussione della comunità
Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.